David Roman, US medtech and healthcare IT research analyst for Goldman Sachs, said that AI play a 'significant' role in helping patients stay on top of their diabetes, with companies like Abbott and Dexcom using new technology to count carbohydrates and deliver the right amount of insulin. Roman, joined by Bloomberg health reporter Madison Muller, said that he came away from Goldman Sach's annual medtech conference 'very bullish' on innovation across the industry. (Source: Bloomberg)

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. (Source: Bloomberg)

Dexcom CEO Jake Leach joined Bloomberg Open Interest to explain why continuous glucose monitors are becoming much bigger than diabetes devices. He says GLP-1 drugs are actually boosting CGM adoption and defends the company’s growth outlook. He also lays out Dexcom’s push into mainstream metabolic health and wellness. (Source: Bloomberg)